CBIO

Crescent Biopharma, Inc.
12.94 -6.37% 2026-11-05

Last 90d 1 insider sale

52-week range
8.72 27.41
1-month-4.1%
3-month-23.2%
1-year+4.0%
3-year-89.6%
5-year-93.2%
vs 50-day-15.4%
vs 200-day-18.5%
Volatility81%
Beta1.07
$ vol/day$3M
ATH2605.00
From ATH-99.5%
Nothing written about CBIO yet. Be the first — call it long or short with an entry we price for you, or post a neutral write-up that takes no side. Create a free account
2026AprJulOct

bought sold · bigger dot, bigger trade · follows the chart’s range

WhenPeople SizeValuePrice
2mo sched 7 $285,501 17.01
4mo buy 1 $20,000,006 14.94
5mo sched 7 $1,226,126 17.48
11mo buy 1 $20,000,130 13.09
4.2y buy 3 $4,582 -94.05
4.7y buy 3 $4,485 -116.60
5.2y buy 3 $9,662 -223.30
5.7y buy 2 $10,832 -420.75

Day-after move, last 6 reports, oldest left.

ReportedEst.Actual SurpriseGapDay 1Day 5
2026-07-30 beat -0.64 -0.62 +2.8% -0.7% +1.7% +11.2%
2026-04-29 beat -0.95 -0.70 +26.0% -0.2% +6.8% -14.0%
2026-02-26 miss -2.82 -4.92 -74.5% -1.6% -1.1% -9.3%
2025-11-06 beat -1.38 -1.37 +1.3% +0.1% +5.4% +4.4%
2025-07-31 miss -3.68 -3.72 -1.1% -2.2% -1.4% -12.7%
2025-06-18 miss -3.64 -18.39 -405.2% +8.5% +2.6% +8.8%
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.1%
Next 1 week
-0.9%
Next 1 month
+1.7%
Seasonality
Bullish window historically
Next 30 days (to Dec 6): +2.3% median, 73% of the last 11 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 31
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.19%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.07 +1.7%
$3M/day volume 81% volatility +4% 1-year
52-week range · 23% of the way up · -53% from the high
$8.72$27.41

Not investment advice.